Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.

Farr K, Ravindran R, Strnad L, Chang E, Chaisson LH, Yoon C, Worodria W, Andama A, Ayakaka I, Bbosa Nalwanga P, Byanyima P, Kalema N, Kaswabuli S, Katagira W, Aman KD, Musisi E, Tumwine NW, Sanyu I, Ssebunya R, Davis JL, Huang L, Khan IH, Cattamanchi A.

PLoS One. 2018 Oct 23;13(10):e0206119. doi: 10.1371/journal.pone.0206119. eCollection 2018.

2.

Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.

Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L, Armstrong DT, Andama AO, Dowdy DW, Davis JL, Huang L, Kamya M, Cattamanchi A.

Lancet Infect Dis. 2017 Dec;17(12):1285-1292. doi: 10.1016/S1473-3099(17)30488-7. Epub 2017 Aug 25.

3.

Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.

Mihret A, Bekele Y, Bobosha K, Kidd M, Aseffa A, Howe R, Walzl G.

J Infect. 2013 Apr;66(4):357-65. doi: 10.1016/j.jinf.2012.11.005. Epub 2012 Nov 20.

PMID:
23178506
4.

Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.

Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L, Khan IH, Cattamanchi A.

PLoS One. 2017 Aug 2;12(8):e0180122. doi: 10.1371/journal.pone.0180122. eCollection 2017.

5.

Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.

Yao X, Liu Y, Liu Y, Liu W, Ye Z, Zheng C, Ge S.

Tuberculosis (Edinb). 2017 Dec;107:88-94. doi: 10.1016/j.tube.2017.07.013. Epub 2017 Aug 3.

PMID:
29050777
6.

Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study.

Davis JL, Huang L, Worodria W, Masur H, Cattamanchi A, Huber C, Miller C, Conville PS, Murray P, Kovacs JA.

PLoS One. 2011 Jan 27;6(1):e16321. doi: 10.1371/journal.pone.0016321.

7.

Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.

Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.

PLoS One. 2015 Jul 29;10(7):e0133756. doi: 10.1371/journal.pone.0133756. eCollection 2015.

8.

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR.

Cochrane Database Syst Rev. 2016 May 10;(5):CD011420. doi: 10.1002/14651858.CD011420.pub2. Review.

9.

Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC.

BMC Infect Dis. 2015 Feb 15;15:62. doi: 10.1186/s12879-015-0812-4.

10.

Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.

Riou C, Perez Peixoto B, Roberts L, Ronacher K, Walzl G, Manca C, Rustomjee R, Mthiyane T, Fallows D, Gray CM, Kaplan G.

PLoS One. 2012;7(5):e36886. doi: 10.1371/journal.pone.0036886. Epub 2012 May 14.

11.

Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.

Cattamanchi A, Ssewenyana I, Nabatanzi R, Miller CR, Den Boon S, Davis JL, Andama A, Worodria W, Yoo SD, Cao H, Huang L.

PLoS One. 2012;7(6):e39838. doi: 10.1371/journal.pone.0039838. Epub 2012 Jun 26.

12.

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.

Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, Grant AD, Churchyard GJ, Kimerling M, Shah S, Lawn SD, Wood R, Maartens G, Granich R, Date AA, Varma JK.

PLoS Med. 2011 Jan 18;8(1):e1000391. doi: 10.1371/journal.pmed.1000391.

13.

Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.

Nakiyingi L, Bwanika JM, Kirenga B, Nakanjako D, Katabira C, Lubega G, Sempa J, Nyesiga B, Albert H, Manabe YC.

PLoS One. 2013 Sep 6;8(9):e74023. doi: 10.1371/journal.pone.0074023. eCollection 2013.

14.

Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.

Mbu ET, Sauter F, Zoufaly A, Bronsvoort BMC, Morgan KL, Noeske J, Abena JF, Sander MS.

PLoS One. 2018 Jun 26;13(6):e0199634. doi: 10.1371/journal.pone.0199634. eCollection 2018.

15.

The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.

Kassa D, de Jager W, Gebremichael G, Alemayehu Y, Ran L, Fransen J, Wolday D, Messele T, Tegbaru B, Ottenhoff TH, van Baarle D.

Tuberculosis (Edinb). 2016 Jan;96:131-40. doi: 10.1016/j.tube.2015.05.015. Epub 2015 Sep 30.

PMID:
26631832
16.

Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.

Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, Freedberg KA, Bassett IV.

BMC Infect Dis. 2014 Feb 26;14:110. doi: 10.1186/1471-2334-14-110.

17.

Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients.

Mihret A, Abebe M, Bekele Y, Aseffa A, Walzl G, Howe R.

BMC Infect Dis. 2014 Mar 4;14:125. doi: 10.1186/1471-2334-14-125.

18.

Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population.

Wilson D, Badri M, Maartens G.

PLoS One. 2011 Jan 10;6(1):e15248. doi: 10.1371/journal.pone.0015248.

19.

Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda.

Nakiyingi L, Nakanwagi P, Briggs J, Agaba T, Mubiru F, Mugenyi M, Ssengooba W, Joloba ML, Manabe YC.

BMC Infect Dis. 2018 Feb 21;18(1):87. doi: 10.1186/s12879-018-2992-1.

20.

IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.

Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM.

J Infect. 2015 Apr;70(4):381-91. doi: 10.1016/j.jinf.2014.12.019. Epub 2015 Jan 15.

Supplemental Content

Support Center